ERAS
Erasca, Inc. (ERAS) 10Y Growth Potential Analysis (2026)
Overall Score
Revenue Growth
No revenue is reported in the fresh metrics, so there is no evidence of current commercial scale.
The company remains pre-revenue or not yet generating measurable sales in the provided data.
Profitability
Margins are still 0% across gross, operating, EBITDA, pretax, and net profit in the fresh ratios.
ROA, ROE, and ROIC remain deeply negative, indicating the business is not yet profitable.
Financial Health
Liquidity is strong with a current ratio of 8.29 and cash ratio of 1.27.
Leverage remains low with debt-to-equity at 0.12 and debt-to-assets at 0.10, though solvency metrics are distorted by negative operating earnings.
Cash Flow
Operating cash flow and free cash flow are still negative, with free cash flow per share at -0.315.
Cash conversion remains poor despite a very low capex burden, so the company is not yet self-funding.
Valuation
Traditional valuation multiples are not meaningful because revenue and operating earnings are not positive.
The market is still assigning a large equity value relative to book value, with price-to-book at 15.55.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Erasca, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

